Skip to content
2000
image of Patents on Xylazine, a Drug Adulterant of Clinical Concern

There is no abstract available.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673394075250723084954
2025-08-21
2025-11-04
Loading full text...

Full text loading...

References

  1. Iacopetta D. Catalano A. Aiello F. Andreu I. Sinicropi M.S. Lentini G. Xylazine, a drug adulterant whose use is spreading in the human population from the U.S. to the U.K. and all Europe: An updated review. Appl. Sci. 2025 15 6 3410 10.3390/app15063410
    [Google Scholar]
  2. Vinnikov A. Sheppard C.W. Wemple A.H. Stern J.E. Leopold M.C. An amperometric sensor with anti-fouling properties for indicating xylazine adulterant in beverages. Micromachines 2024 15 11 1340 10.3390/mi15111340 39597161
    [Google Scholar]
  3. Barletta C. Di Natale V. Esposito M. Chisari M. Cocimano G. Di Mauro L. Salerno M. Sessa F. The rise of fentanyl: Molecular aspects and forensic investigations. Int. J. Mol. Sci. 2025 26 2 444 10.3390/ijms26020444 39859160
    [Google Scholar]
  4. Ball N.S. Knable B.M. Relich T.A. Smathers A.N. Gionfriddo M.R. Nemecek B.D. Montepara C.A. Guarascio A.J. Covvey J.R. Zimmerman D.E. Xylazine poisoning: A systematic review. Clin. Toxicol. (Phila.) 2022 60 8 892 901 10.1080/15563650.2022.2063135 35442125
    [Google Scholar]
  5. Ayub S. Parnia S. Poddar K. Bachu A.K. Sullivan A. Khan A.M. Ahmed S. Jain L. Xylazine in the opioid epidemic: A systematic review of case reports and clinical implications. Cureus 2023 15 3 e36864 10.7759/cureus.36864 37009344
    [Google Scholar]
  6. Kacinko S.L. Mohr A.L.A. Logan B.K. Barbieri E.J. Xylazine: Pharmacology review and prevalence and drug combinations in forensic toxicology casework. J. Anal. Toxicol. 2022 46 8 911 917 10.1093/jat/bkac049 35770859
    [Google Scholar]
  7. Hays H.L. Spiller H.A. DeRienz R.T. Rine N.I. Guo H.T. Seidenfeld M. Michaels N.L. Smith G.A. Evaluation of the relationship of xylazine and fentanyl blood concentrations among fentanyl-associated fatalities. Clin. Toxicol. (Phila.) 2024 62 1 26 31 10.1080/15563650.2024.2309326 38353935
    [Google Scholar]
  8. Kyei E.F. Kyei G.K. Ansong R. Boakye C.K. Asamoah E. Xylazine in the unregulated drug market: An integrative review of its prevalence, health impacts, and detection and intervention challenges in the United States. Policy Polit. Nurs. Pract. 2024 25 4 241 253 10.1177/15271544241268386 39113474
    [Google Scholar]
  9. EspacenetPatent search. Available from: https://worldwide.espacenet.com/patent/search/family
  10. USPTO Global Dossier Available from: https://globaldossier.uspto.gov/
  11. Google Patents Available from: https://patents.google.com/
/content/journals/cmc/10.2174/0109298673394075250723084954
Loading
/content/journals/cmc/10.2174/0109298673394075250723084954
Loading

Data & Media loading...


  • Article Type:
    News
Keywords: Overdose ; fentanyl ; xylazine ; tranq ; alpha2-agonist
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test